ARRY-382 is a highly selective, oral inhibitor of the CSF1R with an IC50 of 9 nM.
[1] David K Edwards V, et al. Oncotarget . 2018 May 15;9(37):24576-24589.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥1,350.00 | 现货 | 1 | |
| 5mg | ¥3,150.00 | 现货 | 1 | |
| 10mg | ¥4,950.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥3,915.00 | 现货 | 1 |
















ARRY-382 is a highly selective, oral inhibitor of the CSF1R with an IC50 of 9 nM.
[1] David K Edwards V, et al. Oncotarget . 2018 May 15;9(37):24576-24589.